Topic: business development
Barclays M&A veteran Elizabeth Mily will take over as business development chief as BMS looks for long-term growth beyond Opdivo.
The departure of BMS' Paul Biondi, who presided over an extensive deal-making strategy, adds to the challenges presented by the Celgene integration.
Ivana Magovčević-Liebisch, Chief Business Officer, Ipsen
Joanne Smith-Farrell, Chief Business Officer, Bluebird Bio
Endo has struggled lately to right the ship, and now it’s giving a new skipper a turn at the wheel.